Estimated Cancer Prevalence by Cancer Site and Gender, New York City, 2019

Source: New York State Cancer Registry

Site of Cancer Diagnosed in Last 5 Years Ever Diagnosed
Males and Females Males Females Males and Females Males Females
All Invasive Malignant Tumors 144,900 67,500 77,300 429,100 192,100 237,000
Oral cavity and pharynx 3,300 2,100 1,200 9,300 5,700 3,600
Esophagus 600 400 200 1,300 900 500
Stomach 2,700 1,500 1,200 7,000 3,900 3,200
Colorectal 12,100 6,200 5,900 38,300 18,100 20,200
Liver / intrahepatic bile duct 2,300 1,600 700 4,500 3,100 1,400
Pancreas 1,800 900 1,000 3,200 1,500 1,700
Larynx 900 700 200 3,200 2,400 700
Lung and bronchus 10,000 4,500 5,500 19,200 8,700 10,500
Melanoma of the skin 4,000 2,100 1,800 13,600 6,700 6,900
Female breast     27,700     91,800
Cervix uteri     1,600     9,400
Corpus uterus and NOS     6,600    
Ovary     1,900     6,900
Prostate   24,500     81,800  
Testis   1,000     5,200  
Urinary bladder (incl. in situ) 5,900 4,400 1,500 16,400 11,900 4,500
Kidney and renal pelvis 5,400 3,400 2,000 15,200 9,300 5,900
Brain and other central nervous system 1,400 800 600 5,400 2,800 2,600
Thyroid 8,900 2,100 6,800 28,000 6,000 22,000
Hodgkin lymphoma 1,200 600 600 6,100 3,100 3,000
Non-Hodgkin lymphomas 6,900 3,500 3,300 20,300 10,300 10,000
Myeloma 3,100 1,600 1,500 5,900 2,900 3,000
Leukemias 4,300 2,400 1,900 11,800 6,500 5,400

Notes

  • Estimated number of residents alive as of January 1, 2019, diagnosed with cancer within the last 5 years or anytime in the past, respectively.
  • Numbers are rounded to the nearest 100.
  • Refer to https://www.naaccr.org/wp-content/uploads/2020/01/CINA12-16.v5.sec1_.pdf for a detailed description of prevalence methodology.